No abstract available
Keywords:
Micellar nanoparticle; co-delivery; multiple drug resistance; siRNA; synergistic effect.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibiotics, Antineoplastic / chemistry*
-
Antibiotics, Antineoplastic / pharmacology
-
Cell Line, Tumor
-
Cell Membrane Permeability
-
Cholesterol / chemistry*
-
Combined Modality Therapy
-
Doxorubicin / chemistry*
-
Doxorubicin / pharmacology
-
Drug Liberation
-
Drug Resistance, Multiple / drug effects
-
Drug Resistance, Neoplasm / drug effects
-
Gene Expression Regulation, Neoplastic / drug effects
-
Gene Silencing
-
Humans
-
Hydrophobic and Hydrophilic Interactions
-
Lymphoma, B-Cell
-
Micelles
-
Nanocapsules / chemistry*
-
Polyesters / chemistry*
-
Polyethylene Glycols / chemistry*
-
Polylysine / chemistry*
-
Proto-Oncogene Proteins c-bcl-2 / genetics
-
Proto-Oncogene Proteins c-bcl-2 / metabolism
-
RNA, Small Interfering / genetics*
-
RNAi Therapeutics
-
Transfection
Substances
-
(O-methylpoly(ethylene glycol)-O'-succinyl)-N-epsilon-poly(L-lysine)
-
Antibiotics, Antineoplastic
-
Micelles
-
Nanocapsules
-
Polyesters
-
Proto-Oncogene Proteins c-bcl-2
-
RNA, Small Interfering
-
methoxy poly(ethylene glycol)-b-poly(epsilon-caprolactone)-b-poly(L-lysine)
-
polycaprolactone
-
Polylysine
-
Polyethylene Glycols
-
Doxorubicin
-
Cholesterol